STOCK TITAN

NASS VY GATEWAY LTD - NSVGF STOCK NEWS

Welcome to our dedicated page for NASS VY GATEWAY news (Ticker: NSVGF), a resource for investors and traders seeking the latest updates and insights on NASS VY GATEWAY stock.

Nass Valley Gateway Ltd (NSVGF) is a publicly traded company focused on the sales and distribution of hemp-based CBD products under the Nass Valley Gardens brand. The company, listed on the CSE, offers products targeting pain relief, skincare, sleep, anti-aging, and beauty. Despite recent delays in financial filings, Nass Valley Gateway remains committed to its growth initiatives and securing strong financial partnerships.

Rhea-AI Summary
Nass Valley Gateway Ltd announces a change in its US subsidiary's capital raise strategy, transitioning from utilizing the Regulation A+ Exemption to engaging alternative capital partners. The initial plan was to raise up to US$75 million through Regulation A+, but the company is now seeking the best financial partner and capital market terms for its growth initiatives in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Nass Valley Gateway Ltd (CSE:NVG) announces a delay in filing its 2022 EOY financials, resulting in a default of the filing requirement and a FFCTO. The delay is due to the finalization of the acquisition of Super Scientific Laboratories by its subsidiary, Nass Valley Gardens Inc. The company has a 30-day remediation plan in place to gather the necessary documents and will provide bi-weekly updates until the filing is completed. CEO Michael Semler emphasizes the importance of stability in the share price and looks forward to satisfying the filing requirement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
-
Rhea-AI Summary
Nass Valley Gateway Ltd. announces that it is working with its auditor to fulfill the requirement of filing its EOY 2022 Financials, MD&A report, and certifications by June 30th, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-36.67%
Tags
none
Rhea-AI Summary

Nass Valley Gardens Inc. announced the acquisition of Super Scientific Laboratories LLC on December 31, 2022. This strategic move aims to enhance product development and distribution channels within the CBD market, including vapes, gummies, and skincare products. CEO Michael Semler emphasized the potential growth and synergy from this partnership, indicating that Super Scientific's capabilities would positively impact Nass Valley's earnings for 2023. Audited financials are forthcoming, and the acquisition involved no finder’s fee. This merger is positioned to strengthen Nass Valley's footprint in the organic, non-GMO hemp-based product landscape.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15%
Tags
none
-
Rhea-AI Summary

Nass Valley Gardens Inc. is set to initiate a Regulation A capital raise upon SEC approval of its Form 1-A. The company has finalized its offering team, including LifeWater Media for marketing and DealMaker for the technical platform. The goal is to raise up to $75M to fund acquisitions, expand product lines, and enhance sales channels. CEO Michael Semler expressed enthusiasm about collaborating with top partners for this endeavor. The press release serves as an information update and does not constitute a sale of securities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Nass Valley Gardens Inc., a subsidiary of Nass Valley Gateway Ltd. (OTC:NSVGF), has announced plans to diversify its product offerings by introducing cosmetics and hemp-based foods. COO Michael Racaniello highlighted that these additional consumer products align with the company's health and wellness strategy and meet the growing demands from their distribution channels. The new products are expected to be available by Q3 2022, enhancing the existing lineup of CBD products focused on various health markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Nass Valley Gardens Inc. announced plans to file with the SEC for a Reg A+ public offering aimed at raising up to US$75 million. Pending SEC approval, the funds will support a NASDAQ listing at $5.00 per share. CEO Michael Semler highlighted the growing opportunities in the CBD consumables market and the need for capital to expand their brand. Proceeds will be utilized for acquiring companies, developing new product lines, and enhancing sales and marketing efforts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.33%
Tags

FAQ

What is the current stock price of NASS VY GATEWAY (NSVGF)?

The current stock price of NASS VY GATEWAY (NSVGF) is $0.02225 as of August 2, 2024.

What is the market cap of NASS VY GATEWAY (NSVGF)?

The market cap of NASS VY GATEWAY (NSVGF) is approximately 24.5M.

What is Nass Valley Gateway Ltd known for?

Nass Valley Gateway Ltd is known for the sales and distribution of hemp-based CBD products under the Nass Valley Gardens brand targeting various markets like pain relief, skincare, sleep, anti-aging, and beauty.

Where is Nass Valley Gateway Ltd listed?

Nass Valley Gateway Ltd is listed on the CSE (Canadian Securities Exchange).

What recent announcement did Nass Valley Gateway Ltd make regarding its financial filings?

Nass Valley Gateway Ltd recently announced delays in its 2022 EOY financial filings, impacting its compliance and subjecting the company to specific filing requirements until remedied.

What is the focus of Nass Valley Gateway Ltd's US subsidiary, Nass Valley Gardens Inc.?

Nass Valley Gardens Inc., the US subsidiary of Nass Valley Gateway Ltd, mainly focuses on the sales and distribution of organic, non-GMO hemp-based CBD products.

What prompted Nass Valley Gardens Inc. to transition its capital raise strategy?

Nass Valley Gardens Inc. decided to shift its capital raise strategy from Regulation A+ to engaging alternative capital partners to secure the best terms and financial partnerships for its growth initiatives.

NASS VY GATEWAY LTD

OTC:NSVGF

NSVGF Rankings

NSVGF Stock Data

24.53M
102.92M
67.03%
Medical Distribution
Healthcare
Link
United States of America
Vancouver